1. Home
  2. BGLC vs FTEL Comparison

BGLC vs FTEL Comparison

Compare BGLC & FTEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGLC
  • FTEL
  • Stock Information
  • Founded
  • BGLC 2017
  • FTEL 2007
  • Country
  • BGLC Malaysia
  • FTEL Australia
  • Employees
  • BGLC N/A
  • FTEL N/A
  • Industry
  • BGLC Medical Specialities
  • FTEL
  • Sector
  • BGLC Health Care
  • FTEL
  • Exchange
  • BGLC Nasdaq
  • FTEL Nasdaq
  • Market Cap
  • BGLC 10.4M
  • FTEL 9.8M
  • IPO Year
  • BGLC N/A
  • FTEL 2023
  • Fundamental
  • Price
  • BGLC $5.66
  • FTEL $0.48
  • Analyst Decision
  • BGLC
  • FTEL
  • Analyst Count
  • BGLC 0
  • FTEL 0
  • Target Price
  • BGLC N/A
  • FTEL N/A
  • AVG Volume (30 Days)
  • BGLC 53.1K
  • FTEL 55.7K
  • Earning Date
  • BGLC 08-18-2025
  • FTEL 04-28-2025
  • Dividend Yield
  • BGLC N/A
  • FTEL N/A
  • EPS Growth
  • BGLC N/A
  • FTEL N/A
  • EPS
  • BGLC N/A
  • FTEL N/A
  • Revenue
  • BGLC $9,551,559.00
  • FTEL $4,990,695.00
  • Revenue This Year
  • BGLC N/A
  • FTEL N/A
  • Revenue Next Year
  • BGLC N/A
  • FTEL N/A
  • P/E Ratio
  • BGLC N/A
  • FTEL N/A
  • Revenue Growth
  • BGLC 4.01
  • FTEL 29.02
  • 52 Week Low
  • BGLC $2.01
  • FTEL $0.36
  • 52 Week High
  • BGLC $15.60
  • FTEL $49.50
  • Technical
  • Relative Strength Index (RSI)
  • BGLC 52.45
  • FTEL 43.52
  • Support Level
  • BGLC $5.45
  • FTEL $0.44
  • Resistance Level
  • BGLC $5.81
  • FTEL $0.51
  • Average True Range (ATR)
  • BGLC 0.20
  • FTEL 0.04
  • MACD
  • BGLC -0.02
  • FTEL 0.00
  • Stochastic Oscillator
  • BGLC 77.94
  • FTEL 29.58

About BGLC BioNexus Gene Lab Corp Common stock

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About FTEL Fitell Corporation

Fitell Corp engages in primary operations of selling gym and fitness equipment in Australia through its indirectly held wholly owned subsidiaries. It operates in two segments: online fitness equipment distribution and licensing business to service the large and growing boutique fitness sector of the broader health and fitness club industry. The majority fitness equipment business is conducted in Australia via its own e-commerce platform and, through third-party sites. Licensing service offers a turnkey solution for personal training studios and commercial gym chains. The company earns maximum of revenue for retail.

Share on Social Networks: